- Conditions: Type 1 Diabetes; Type 2 Diabetes
Intervention:
Sponsors: Metabolic Fitness Association, Italy; Metabolic Fitness Association, Italy; University of Roma La Sapienza
Recruiting - verified May 2012 - Condition: Type 2 Diabetes
Intervention: Behavioral: Theoretical & practical exercise counseling
Sponsors: Metabolic Fitness Association, Italy; Metabolic Fitness Association, Italy; University of Roma La Sapienza
Not yet recruiting - verified May 2012 - Conditions: cUTI; Complicated Urinary Tract Infection; Acute Pyelonephritis
Interventions: Drug: CAZ-AVI; Drug: Doripenem
Sponsors: AstraZeneca; AstraZeneca; Cerexa, Inc.
Not yet recruiting - verified May 2012 - Conditions: Type 2 Diabetes Mellitus; Atherosclerosis; Dyslipidemia
Intervention: Other: Statin withdrawal
Sponsors: University of Padova; University of Padova
Not yet recruiting - verified May 2012 - Conditions: Plaque Ph Lowering After Use of Probiotics; Caries
Intervention: Dietary Supplement: comsumption of lozenges
Sponsors: Università degli Studi di Sassari; Università degli Studi di Sassari
Active, not recruiting - verified May 2012 - Condition: Human Immunodeficiency Virus
Interventions: Drug: Atazanavir, ritonavir, lamivudine; Drug: Atazanavir, Ritonavir, 2 NRTIs
Sponsors: Catholic University of the Sacred Heart; Catholic University of the Sacred Heart
Recruiting - verified May 2012 - Conditions: Surgery; Anaesthesia; Ventilator-Induced Lung Injury; Lung Injury; Pneumonia; Pneumothorax; Respiratory Distress Syndrome, Adult; Respiratory Insufficiency
Intervention:
Sponsors: European Society of Anaesthesiology; European Society of Anaesthesiology; Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Not yet recruiting - verified May 2012 - Condition: Spontaneous Bacterial Peritonitis
Intervention: Other: Diagnostic tests
Sponsors: Azienda Ospedaliera di Lecco; Azienda Ospedaliera di Lecco
Not yet recruiting - verified May 2012 - Condition: Multiple Sclerosis
Interventions: Drug: PR Fampridine; Other: Placebo
Sponsors: Biogen Idec; Biogen Idec
Not yet recruiting - verified May 2012 - Condition: Femoral Fractures
Intervention: Device: EBA2
Sponsors: Citieffe S.r.l; Citieffe S.r.l; Opera Srl
Recruiting - verified May 2012 - Condition: Polycystic Ovary Syndrome
Intervention: Drug: Metformin
Sponsors: Catholic University of the Sacred Heart; Catholic University of the Sacred Heart
Completed - verified May 2012 - Condition: Acute Kidney Injury
Interventions: Drug: Aminophylline; Drug: Hydration plus N-acetylcisteine
Sponsors: Ospedale Misericordia e Dolce; Ospedale Misericordia e Dolce
Recruiting - verified May 2012 - Conditions: Post Operative Pain; Hyperalgesia
Interventions: Drug: ketamine infusion; Drug: Methadone PCA
Sponsors: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano; Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Recruiting - verified May 2012 - Condition: Multivessel Coronary Artery Disease
Interventions: Procedure: BIMA Grafting; Procedure: Left-only mammary artery grafting
Sponsors: Catholic University, Italy; Catholic University, Italy
Not yet recruiting - verified May 2012 - Condition: Branch Retinal Vein Occlusion
Interventions: Drug: Ranibizumab; Procedure: Laser
Sponsors: Novartis; Novartis Pharmaceuticals
Not yet recruiting - verified May 2012 - Condition: Dermoid Ovarian Cysts
Intervention: Procedure: Laparoscopic dermoid cystectomy
Sponsors: University Magna Graecia; University Magna Graecia
Completed - verified May 2012 - Conditions: The Primary Study Objective is to Assess the Efficacy and; Safety of Extended 4-week Heparin Prophylaxis Compared to; Prophylaxis Given for 8±2 Days After Planned Laparoscopic; Surgery for Colorectal Cancer.; The Clinical Benefit Will be Evaluated as the Difference in; the Incidence of VTE or VTE-related Death Occurring Within 30 Days; From Surgery in the Two Study Groups.
Intervention: Drug: Heparin, Low-Molecular-Weight
Sponsors: University Of Perugia; University Of Perugia
Recruiting - verified April 2012 - Condition: Acute Lymphoblastic Leukemia
Intervention: Drug: liposomal cytarabine
Sponsors: National Cancer Institute, Naples; National Cancer Institute, Naples; Santobono-Pausilpon Hospital; Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi; University of Bologna
Recruiting - verified May 2012 - Condition: Paraesophageal Hernia
Intervention: Procedure: laparoscopic surgery
Sponsors: University of Bologna; University of Bologna
Completed - verified April 2012 - Condition: Caries
Intervention: Other: Sealant application
Sponsors: Università degli Studi di Sassari; Università degli Studi di Sassari; WHO Collaborating Centre for Epidemiology and Community Dentistry
Completed - verified April 2012 - Condition: Septic Patients
Intervention: Biological: Blood transfusion
Sponsors: Università Politecnica delle Marche; Università Politecnica delle Marche; Azienda Ospedaliero-Universitaria Ospedali Riuniti Ancona
Completed - verified April 2012 - Conditions: Guillain-Barré Syndrome; Miller Fisher Syndrome
Intervention:
Sponsors: Erasmus Medical Center; Erasmus Medical Center
Recruiting - verified May 2012 - Conditions: Obesity With Complications; Morbid Obesity; Reactive Hypoglycemia; Bariatric Surgery
Interventions: Procedure: Gastric Bypass; Procedure: Sleeve Gastrectomy
Sponsors: Catholic University of the Sacred Heart; Catholic University of the Sacred Heart
Not yet recruiting - verified April 2012 - Condition: Polycystic Ovary Syndrome
Interventions: Drug: Metformin; Drug: Yasmin;; Drug: Metformin plus Yasmin
Sponsors: Catholic University of the Sacred Heart; Catholic University of the Sacred Heart
Completed - verified April 2012 - Condition: Glioblastoma
Interventions: Drug: LY2157299 monohydrate; Drug: Lomustine; Drug: Placebo
Sponsors: Eli Lilly and Company; Eli Lilly and Company
Recruiting - verified May 2012 - Condition: Uremia
Interventions: Procedure: online pre-dilution hemofiltration; Procedure: online pre-dilution hemodiafiltration
Sponsors: A. Manzoni Hospital; A. Manzoni Hospital
Completed - verified April 2012 - Conditions: Intraocular Pressure (IOP); Tear Break-Up Time
Interventions: Drug: IOPIZE© Latanoprost eyedrops; Drug: GALAXIA© Latanoprost eyedrops; Drug: Latanoprost RATIOPHARM© latanoprost eyedrops
Sponsors: University of Cantanzaro; University of Cantanzaro
Recruiting - verified April 2012
 |
Find Paid Clinical Trials in Italy |
Clinical Trial Locations 